Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

FENOLDOPAM MESYLATE

FENOLDOPAM MESYLATE

Standard Dose
EQ 10MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview FENOLDOPAM MESYLATE is listed in Drugs@FDA under application 077826 (ANDA).

Marketing status: Discontinued Active ingredient FENOLDOPAM MESYLATE Form and strength INJECTABLE;INJECTION - EQ 10MG BASE/ML Sponsor TEVA PARENTERAL Submission history Latest submission status date: 2007-03-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview FENOLDOPAM MESYLATE is listed in Drugs@FDA under application 077826 (ANDA). Marketing status: Discontinued Active ingredient FENOLDOPAM MESYLATE Form and strength INJECTABLE;INJECTION - EQ 10MG BASE/ML Sponsor TEVA PARENTERAL Submission history Latest submission status date: 2007-03-07 00:00:00. Submission type: ORIG.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.